2003BloodRequires access

Lack of alteration in GATA-1 expression in CD34+ hematopoietic progenitors from patients with idiopathic myelofibrosis

Marie‐Claire Martyré, Virginie Steunou, Marie-Caroline Lebousse-Kerdiles, Juana Wietzerbin

Open publisher page 24 citations

Abstract

Idiopathic myelofibrosis (IM), also known as myelofibrosis with myeloid metaplasia, is a myeloproliferative disorder of clonal origin characterized by extramedullary hematopoiesis with a leukoerythroblastic blood picture, tear-drop erythrocytes, and progressive splenomegaly associated with bone

About this research paper

What this paper is about

Idiopathic myelofibrosis (IM), also known as myelofibrosis with myeloid metaplasia, is a myeloproliferative disorder of clonal origin characterized by extramedullary hematopoiesis with a leukoerythroblastic blood picture, tear-drop erythrocytes, and progressive splenomegaly associated with bone

Why it matters

OpenAlex reports 24 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Idiopathic myelofibrosis (IM), also known as myelofibrosis with myeloid metaplasia, is a myeloproliferative disorder of clonal origin characterized by extramedullary hematopoiesis with a leukoerythroblastic blood picture, tear-drop erythrocytes, and progressive splenomegaly associated with bone

Key concepts: Myelofibrosis, Extramedullary hematopoiesis, Haematopoiesis, CD34, Myeloid, Metaplasia, Medicine, Pathology

Related papers

Back to paper searchBrowse research topicsOriginal source
Lack of alteration in GATA-1 expression in CD34+ hematopoietic progenitors from patients with idiopathic myelofibrosis — Research Paper | ScholarLens